PharmiWeb52m
Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011
Patent Secures Protection for RLF-TD011 in Epidermolysis Bullosa Wound Treatment GENEVA, SWITZERLAND / ACCESS Newswire / February 11, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB ...
PharmiWeb2h
BIOVERSYS SUCCESSFULLY ADVANCES BV500 NTM PROGRAM WITH CONTINUED SUPPORT FROM CF AMR SYNDICATE
MiscellaneousBIOVERSYS SUCCESSFULLY ADVANCES BV500 NTM PROGRAM WITH CONTINUED SUPPORT FROM CF AMR SYNDICATE 11.02.2025 / 07:00 CET/CESTBasel, Switzerland. February 11, 2025, 7am CET  BV500 reaches ...
PharmiWeb7h
Onco-Innovations' Licensed PNKP Inhibitor Technology Shown to Increase Sensitivity of Cancer Cells to Radiation in Animal Study
VANCOUVER, BC / ACCESS Newswire / February 10, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H ,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to provide information on its ...
PharmiWeb9h
Jolt Health Inc. Announces Share Consolidation
VANCOUVER, BC / ACCESS Newswire / February 10, 2025 / Jolt Health Inc. ("JOLT" and or "the Company") (CSE:JOLT)(FSE:G1Q0) announces it intends to proceed with a consolidation of its common shares ...
PharmiWeb10h
Black Book Research Releases First Industry-Wide Evaluation of AI-Driven Revenue Cycle Management Solutions
New Report Identifies 80 Leading Vendors, AI-Centric KPIs, and Initial ROI Trends in Healthcare Finance NEW YORK CITY, NEW YORK / ACCESS Newswire / February 10, 2025 / Black Book Market Research, a ...
PharmiWeb12h
Cosmos Health Advances Cancer Treatment Innovation…
CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...
PharmiWeb13h
Next Gen Diagnostics Announces That the University of Pittsburgh Has Joined the NGD Consortium
CAMBRIDGE, MA AND PITTSBURGH, PA / ACCESS Newswire / February 10, 2025 / Next Gen Diagnostics (NGD), a pioneer in the development of machine learning models for whole genome sequence- (WGS-) based ...
PharmiWeb15h
Key Innovations Driving Growth in the Cardiogenic Shock Treatment Market
Explore the latest innovations in cardiogenic shock treatment, including advances in mechanical circulatory support devices, ...
PharmiWeb15h
Ourvita’s strategic acquisition of Laboratoria Natury
Ourvita strengthens their European presence with acquisition  of leading Polish food supplement manufacturer Laboratoria Natury Ourvita, a global leader in the development and manufacturing of health ...
PharmiWeb15h
Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis
Qureight Ltd, the Core Imaging Laboratory developing deep-learning image analytics, and Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on developing inhaled therapies to treat ...
PharmiWeb16h
Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations
CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...
PharmiWeb17h
An Incredible KLAS Triple-Award Win for AGFA HealthCare!
MORTSEL, BE / ACCESS Newswire / February 10, 2025 / AGFA HealthCare proudly celebrates a remarkable KLAS triple-win, securing two #1 Best in KLAS Awards for XERO® Viewer and VNA, alongside the KLAS ...